30 Day Psychedelic Pharmacology Podcast - Day 21 Gut Microbiome Interactions episode artwork

EPISODE · Jan 30, 2025 · 18 MIN

30 Day Psychedelic Pharmacology Podcast - Day 21 Gut Microbiome Interactions

from Cannabinoid and Psychedelic Pharmacology and Drug Development

This episode explores the fascinating connection between the gut microbiome and psychedelic therapy. The discussion delves into how trillions of gut bacteria might influence the effectiveness of psychedelic treatments through their production of metabolites and interaction with serotonin systems. Key topics include the role of the 5-HT2A receptor in psychedelic effects, MDMA's therapeutic potential for PTSD, and the possibility of personalizing psychedelic therapy based on an individual's gut microbiome composition. The conversation also examines a 2024 study showing how positive mindset and supportive environments lead to better outcomes in psychedelic experiences.

Episode metadata supplied by the publisher feed · Published Jan 30, 2025

Embed this episode

NOW PLAYING

30 Day Psychedelic Pharmacology Podcast - Day 21 Gut Microbiome Interactions

0:00 18:45

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Cannabinoid and Psychedelic Pharmacology and Drug Development?

This episode is 18 minutes long.

When was this Cannabinoid and Psychedelic Pharmacology and Drug Development episode published?

This episode was published on January 30, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Cannabinoid and Psychedelic Pharmacology and Drug Development episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!